Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Reports outline life sciences study results from W. Magliani et al
January 14th, 2009
Current study results from the report, 'From yeast killer toxins to antibiobodies and beyond,' have been published. According to recent research from Parma, Italy, "Antibiobodies are paradigmatic of yeast killer toxin (KT)-like antibodies (KAbs) mimicking the antimicrobial activity of KTs in the frame of the yeast killer phenomenon. Polyclonal, monoclonal and recombinant anti-idiotypic antibiobodies (anti-idiotypic KAbs), internal images of a wide-spectrum KT produced by the yeast Pichia anomala (PaKT), have been produced by immunization with the idiotype of a PaKT-neutralizing monoclonal antibody." "Anti-idiotypic KAbs showed microbicidal activity against eukaryotic...
Source: Vaccine Weekly (2009-01-14)
|
